Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis

Chemistry and Physics of Lipids

Volumn 186, Issue , 2015, Pages 9-16

  Pradhan, Madhulika ^a   Singh, Deependra ^a   Singh, Manju Rawat ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Box Behnken design; Fluocinolone acetonide; Psoriasis; Solid lipid nanoparticles; Topical delivery

Indexed keywords

ACETYLSALICYLIC ACID; FLUOCINOLONE ACETONIDE; SOLID LIPID NANOPARTICLE; ANTIINFLAMMATORY AGENT; DRUG CARRIER; LIPID; NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; BOX BEHNKEN DESIGN; COMPUTER PROGRAM; CONTROLLED STUDY; DEVELOPMENT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; EMULSION; ENCAPSULATION; EPIDERMIS; IN VITRO STUDY; KINETICS; NONHUMAN; PARTICLE SIZE; PSORIASIS; RESPONSE SURFACE METHOD; SKIN PERMEABILITY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; GOAT; METABOLISM; SKIN; SKIN ABSORPTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG CARRIERS; FLUOCINOLONE ACETONIDE; GOATS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PSORIASIS; SKIN; SKIN ABSORPTION; X-RAY DIFFRACTION;

EID: 84919363462     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2014.11.004     Document Type: Article

References (22)

1. Das, S., Ng, W.K., Kanaujia, P., Kim, S., Tan, R.B.H., 2011. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf. B 88, 483-489.
2. Ghadiri, M., Fatemi, S., Vatanara, A., Doroud, D., Najafabadi, A.R., Darabi, M., Rahimi, A.A., 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int. J. Pharm. 424, 128-137.
3. Jenning, V., Gysler, A., Schafer-Korting, M., Gohla, S.H., 2000. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211-218.
4. Khurana, S., Bedi, P.M.S., Jain, N.K., 2013a. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem. Phys. Lipids 175, 65-72.
5. Khurana, S., Jain, N.K., Bedi, P.M.S., 2013b. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sci. 93, 763-772.
6. Kilfoyle, B.E., Sheihet, L., Zhang, Z., Laohoo, M., Kohn, J., Michniak-Kohn, B.B., 2012. Development of paclitaxel-Tyro Spheres for topical skin treatment. J. Controlled Release 163, 18-24.
7. Lason, E., Sikora, E., Ogonowski, J., 2013. Influence of process parameters on properties of nanostructured lipid carriers (NLC) formulation. Acta Biochim. Pol. 60, 773-777.
8. Liu, J., Hu, W., Chen, H., Ni, Q., Xu, H., Yang, X., 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328, 191-195.
9. Liu, M., Dong, J., Yang, Y., Yang, X., Xu, H., 2005. Characterization and release of triptolide-loaded poly(D: L-lactic acid) nanoparticles. Eur. Polym. J. 41, 375-382.
10. Mei, Z., Chen, H., Wang, T., Yang, Y., Yang, X., 2003. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J Pharm. Biopharm. 56, 189-196.
11. Nestle, F.O., Kaplan, D.H., Barker, J., 2009. Psoriasis. N. Engl. J. Med. 361, 496-509.
12. Pauporte, M., Maibach, H., Lowe, N., Pugliese, M., Friedman, D.J., Mendelsohn, H., Cargill, I., Ramirez, R., 2004. Fluocinolone acetonide topical oil for scalp psoriasis. J. Dermatolog. Treat. 15, 360-364.
13. Pradhan, M., Singh, D., Singh, M.R., 2013. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J. Controlled Release 170, 380-395.
14. Prow, T.W., Grice, J.E., Lin, L.L., Faye, R., Butler, M., Becker, W., Wurm, E.M.T., Yoong, C., Robertson, T.A., Soyer, H.P., Roberts, M.S., 2011. Nanoparticles and microparticles for skin drug delivery. Adv. Drug Delivery Rev. 63, 470-491.
15. Raposo, S.C., Simoes, S.D., Almeida, A.J., Ribeiro, H.M., 2013. Advanced systems for glucocorticoids' dermal delivery. Expert Opin. Drug Deliv. 10, 857-877.
16. Rawat, M., Saraf, S., 2009. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres. J. Microencapsul. 26, 306-314.
17. Rawat, M., Saraf, S., 2007. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS Pharm. Sci. Tech. 8, 289-297.
18. Sawant, K.K., Agrawal, Y., Petkar, K.C., 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis, Int. J. Pharm. 401, 93-102.
19. Schafer-Korting, M., Mehnert, W., Korting, H.C., 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Delivery Rev. 59, 427-443.
20. Singh, D., Dubey, P., Pradhan, M., Singh, M.R., 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin. Drug Deliv. 10, 241-259.
21. Singh, D., Nag, M., Pradhan, M., Singh, M.R., 2014. Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif. Cells Nanomed. Biotechnol. doi: http://dx.doi.org/10.3109/21691401.2014.883401 (Early Online: 1-9).
22. Stern, R.S., Nijsten, T., Feldman, S.R., Margolis, D.J., Rolstad, T., 2004. Psoriasis is common: carries a substantial burden even when not extensive and is associated with widespread treatment dissatisfaction. J Invest. Dermatol. Symp. Proc. 9, 136-139.